共 282 条
[1]
Basu B(2009)Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies Expert Rev Anticancer Ther 9 1583-1598
[2]
Biswas S(2006)Somatic activation of KIT in distinct subtypes of melanoma J Clin Oncol 24 4340-4346
[3]
Wrigley J(2005)Angiogenesis: update 2005 J Thromb Haemost 3 1835-1842
[4]
Sirohi B(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
[5]
Corrie P(2006)The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; a review Eur J Cancer 42 3127-3139
[6]
Curtin JA(2006)Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer J Clin Oncol 24 25-35
[7]
Busam K(2003)The biology of VEGF and its receptors Nat Med 9 669-676
[8]
Pinkel D(1972)Anti-angiogenesis: new concept for therapy of solid tumors Ann Surg 175 409-416
[9]
Bastian BC(2007)A phase I dose finding study of E7080 in patients (pts) with advanced malignancies J Clin Oncol 25 617s-2909
[10]
Dvorak HF(2008)A phase I study of E7080 in patients (pts) with advanced malignancies J Clin Oncol 26 159s-904